OnKure Therapeutics, Inc. (OKUR) — Cash Flow-to-Debt Ratio
OnKure Therapeutics, Inc. (OKUR) has a Cash Flow-to-Debt Ratio of -2.03x as of September 2025, meaning its operating cash flow of $-13.04 Million could theoretically repay -2% of its total liabilities ($6.41 Million) in one year. See OKUR free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
OnKure Therapeutics, Inc. Cash Flow-to-Debt Ratio (2020–2024)
Historical debt coverage capacity for OnKure Therapeutics, Inc. across 5 annual periods. Also explore OKUR year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for OnKure Therapeutics, Inc. (2020–2024)
Year-by-year debt coverage analysis for OnKure Therapeutics, Inc.. For market capitalisation and broader financial context, see OKUR stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.61x | $-51.12 Million | $11.08 Million | ▼ -1737.4% |
| 2023 | -0.25x | $-34.55 Million | $137.58 Million | ▲ +34.4% |
| 2022 | -0.38x | $-26.95 Million | $70.42 Million | ▲ +93.1% |
| 2021 | -5.58x | $-37.98 Million | $6.81 Million | ▼ -2827.6% |
| 2020 | -0.19x | $-18.54 Million | $97.34 Million | — |